Nicholas Grund

Insider Reports History

Entity
Individual
Location
C/O Amag Pharmaceuticals, Inc., Waltham, MA
Signature
/s/Carolyn Rucci, attorney-in-fact for Nicholas Grund
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas Grund:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. Chief Commercial Officer Common Stock 443K $929K $2.10 Feb 3, 2025 Direct
Akebia Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to buy) 292K Jan 31, 2025 Direct

Insider Reports Filed by Nicholas Grund

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKBA Akebia Therapeutics, Inc. Jan 31, 2025 3 -$117K 4 Feb 4, 2025 Chief Commercial Officer
AKBA Akebia Therapeutics, Inc. Jan 31, 2024 2 $0 4 Feb 2, 2024 Chief Commercial Officer
AKBA Akebia Therapeutics, Inc. Jan 8, 2024 0 $0 3 Jan 18, 2024 Chief Commercial Officer